Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 January 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

New diagnosis of Barrett's esophagus changes insurance status

A diagnosis of Barrett's esophagus more than doubles life insurance premiums, and impacts the availability of health insurance, reports March's issue of The American Journal of Gastroenterology.

News image

fiogf49gjkf04

Barrett's esophagus is associated with an increased risk of adenocarcinoma of the esophagus.

Despite this increased risk, most cohort studies demonstrate that the mean life expectancy of subjects with Barrett's esophagus is no different than age-matched controls.

The indirect costs associated with a diagnosis of Barrett's esophagus are unclear.

Dr Shaheen and colleagues assessed the effect of a diagnosis of Barrett's esophagus on insurance premiums.

The researchers assessed 20 national life insurance companies (10 in southern California, 10 in North Carolina) to determine the effect of a diagnosis of Barrett's esophagus on life insurance premiums.

The investigators’ base case in Los Angeles was a 36 year old female nonsmoker, and in North Carolina, a 43 year old Caucasian male nonsmoker, both in excellent health except for a diagnosis of prevalent Barrett's esophagus with no dysplasia.

The investigative team then requested a policy of 20 year guaranteed term life insurance in the amount of $1,000,000.

Companies refused to provide health insurance to the individual with Barrett's esophagus or requested further medical review
The American Journal of Gastroenterology

Companies were asked for their best price exclusive of the Barrett's esophagus, and also their best price when considering Barrett's esophagus as a preexisting condition.

The researchers subsequently sent a physician's letter explaining Barrett's esophagus and providing data substantiating a normal life expectancy in the condition to those companies not offering the "preferred" rates.

The team also asked companies for health insurance quotes, including premiums and deductibles, inclusive and exclusive of the diagnosis of Barrett's esophagus.

The investigators contacted 29 national insurance companies and for the 43 year old man with no Barrett's esophagus, the yearly "preferred" premium for life insurance averaged $1,255.

The mean cost of the policies offered to the same individual with Barrett's esophagus as a preexisting condition was $2,731.

The researchers noted that for the 36 year old female the base rate exclusive of Barrett's esophagus was $517, with a range of $472 - $551.

After inclusion of the diagnosis of Barrett's esophagus, the mean rate rose by 177%, to $1,434, with a range of $1,144 - $1,896.

The investigators reported that companies either refused to provide health insurance to the individual with Barrett's esophagus or would not provide a quote without review of the medical record.

The team observed that none of the insurance companies changed their quoted rates after receiving the letter written by the physician on behalf of the individual.

Dr Shaheen concludes, “Despite the preponderance of data demonstrating a normal life expectancy associated with the condition, a diagnosis of Barrett's esophagus more than doubles life insurance premiums, and impacts the availability of health insurance.”

“Further steps to educate insurance companies about the risks associated with Barrett's esophagus are warranted, and patients should understand this additional "risk" of endoscopic screening for Barrett's esophagus.”

“There are significant indirect costs associated with a diagnosis of Barrett's esophagus.”

The American Journal of Gastroenterology 2005: 100(3): 577
09 March 2005

Go to top of page Email this page Email this page to a colleague

 24 January 2018 
Risk factors underlying previously undiagnosed cirrhosis
 24 January 2018 
Ethnicity influences phenotype in IBD
 24 January 2018 
Bariatric surgery vs medical obesity treatment
 23 January 2018 
Atrophic gastritis after H. pylori eradication
 23 January 2018 
Ectopic pregnancy in women with IBD
 23 January 2018 
Celiac disease in IBS in the USA
 22 January 2018 
Costs of biologic therapies for IBD in the USA
 22 January 2018 
Western vs Asian guidelines for colon cancer management
 22 January 2018 
Improving symptoms in GERD
 19 January 2018 
Predicting the risk of early surgery in Crohn’s
 19 January 2018 
Ileoanal pouch microbiota
 19 January 2018 
Lifestyle intervention vs gastric bypass for obesity and diabetes
 18 January 2018 
Sleeve gastrectomy vs Roux-en-Y gastric bypass
 18 January 2018 
Healthcare costs of liver cancer in the USA
 18 January 2018 
High-risk adenomas at colonoscopy
 17 January 2018 
“Weekend effect” in upper GI hemorrhage
 17 January 2018 
Gut dysbiosis and non-antibiotic prescription medications
 17 January 2018 
Reducing surgical infections in high-outlier colorectal unit
 16 January 2018 
Bundle of care in GI cancer surgery
 16 January 2018 
Anxiety about colonoscopy
 16 January 2018 
Thiopurines and colorectal neoplasia in IBD
 15 January 2018 
Risks of death after liver transplants for liver cancer
 15 January 2018 
Recent advances in hepatocellular carcinoma
 15 January 2018 
Ileostomy output using telemedicine
 12 January 2018 
Surveillance protocols after colorectal cancer resection
 12 January 2018 
Biologic therapy by pregnant women with IBD and infant vaccines
 12 January 2018 
Biologic therapies for IBD in the USA
 11 January 2018 
Genetic risk factors in GERD
 11 January 2018 
Predictor of colorectal adenoma
 11 January 2018 
Ectopic pregnancy in IBD 
 10 January 2018 
Fecal immunochemical tests for colorectal cancer screening
 10 January 2018 
Risk factors for advanced NAFLD
 10 January 2018 
Dyspepsia prevalence with gastroesophageal reflux–type symptoms
 09 January 2018 
Screening intervals for people with family histories of colorectal cancer
 09 January 2018 
Financial impact of colorectal cancer
 09 January 2018 
Current practice and future research in autoimmune hepatitis
 08 January 2018 
Reliability of the IBD index
 08 January 2018 
Improving prognosis in patients with primary sclerosing cholangitis
 08 January 2018 
Aprepitant and nausea with gastroparesis
 05 January 2018 
Autoimmune pancreatitis and IBD
 05 January 2018 
Primary nonresponse to infliximab therapy
 05 January 2018 
Anesthesia assistance in outpatient colonoscopy
 04 January 2018 
Dietary polyphenols in the etiology of IBD
 04 January 2018 
Yoga vs low-FODMAP in IBS
 04 January 2018 
Local esophageal food allergen injections in eosinophilic esophagitis
 03 January 2018 
Population health management for IBD
 03 January 2018 
GERD in asthma and COPD
 03 January 2018 
Critical research gaps in colorectal cancer
 22 December 2017 
Costs of extrahepatic manifestations of Hep C
 22 December 2017 
Cholera vaccine and risk of death in colorectal cancer
 22 December 2017 
Colonoscopy after colorectal cancer resection
 21 December 2017 
Human oral microbiome and pancreatic cancer risk
 21 December 2017 
Health management for IBD
 21 December 2017 
PPI and Alzheimer's disease
 20 December 2017 
Management of abnormal liver blood tests
 20 December 2017 
Incidence of biopsy-verified celiac disease
 20 December 2017 
Osteoporotic fractures in Barrett's esophagus
 19 December 2017 
Alcohol abstinence and alcoholic hepatitis
 19 December 2017 
Family burden of pediatric Crohn's in the USA
 19 December 2017 
Early readmission in IBD patients

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us